APH
Amphenol Corporation
APH has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS
AST SpaceMobile, Inc.
ASTS trails on the overall score without a compensating advantage in the available component scores.
APH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Healthy |
APH's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
APH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $79.62 | — |
| Cheap | 26x | $60.41 | -24% |
| Fair | 33x | $76.08 | -4.4% |
| Current | 35x | $79.62 | — |
| Expensive | 42x | $96.05 | +21% |
Historical ranges are pointers, not guarantees.
APH's PE is in its fair range at 35x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its cheap range.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
APH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for APH, with profitability improving.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
APH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.46 | +50% |
| Q3 2026 | $2.30 | +53% |
| Q2 2026 | $1.99 | +58% |
| Q1 2026 | $1.74 | +69% |
| Q4 2025 | $1.67 | +74% |
| Q3 2025 | $1.50 | +72% |
| Q2 2025 | $1.26 | +50% |
| Q1 2025 | $1.03 | +26% |
| Q4 2024 | $0.96 | +23% |
APH has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
APH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.2B | +65% |
| Q2 2026 | $8.8B | +55% |
| Q1 2026 | $7.6B | +58% |
| Q4 2025 | $6.4B | +49% |
| Q3 2025 | $6.2B | +53% |
| Q2 2025 | $5.7B | +57% |
| Q1 2025 | $4.8B | +48% |
| Q4 2024 | $4.3B | +30% |
APH's revenue has grown year over year for 12 quarters in a row: $10.2B last quarter, up 65% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +2.1 points |
| Q2 2026 | 30% | +4.4 points |
| Q1 2026 | 24% | +2.7 points |
| Q4 2025 | 27% | +4.7 points |
| Q3 2025 | 27% | +7.2 points |
| Q2 2025 | 25% | +5.8 points |
| Q1 2025 | 21% | +0.3 points |
| Q4 2024 | 22% | +1.4 points |
APH has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
APH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +34% |
| Q2 2026 | $1.2B | +7.3% |
| Q1 2026 | $829.9M | +44% |
| Q4 2025 | $1.5B | +127% |
| Q3 2025 | $1.2B | +156% |
| Q2 2025 | $1.1B | +114% |
| Q1 2025 | $576.3M | +14% |
| Q4 2024 | $647.3M | -12% |
APH has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
APH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +4.5M shares |
| 1 year | +0.7% | +17.3M shares |
| 3 years | +3.8% | +94.9M shares |
| 5 years | +3.2% | +79.7M shares |
| Available history | +4.9% | +120M shares |
APH has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $244.6M |
| Q2 2026 | $208M |
| Q1 2026 | $178M |
| Q4 2025 | $171.3M |
| Q3 2025 | $152.9M |
| Q2 2025 | $160.1M |
| Q1 2025 | $180.9M |
| Q4 2024 | $168.9M |
APH spent $802M buying back its own shares over the past year, up 21% from the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
APH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.0x | Very low |
APH's net debt is about 1.3 years of its operating earnings (EBITDA), up from less than a year a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
APH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 36.3 | Neutral |
APH's weekly RSI is 52 (neutral) and its Stochastic is 36 (neutral).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
APH PE vs Technology Sector
| Metric | APH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 24% above |
| PE % | 59 | 35 | 24 pts above |
APH is trading at 35x earnings, a 24% premium to the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
APH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.7 | 1.3% below |
| 20 week MA | $80.5 | 1% below |
| 50 week MA | $74.5 | 6.9% above |
| 100 week MA | $60.8 | 31% above |
| 200 week MA | $43.4 | 83% above |
APH has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
APH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.5 | $16.2 | +20% |
| 2021 | $16.2 | $21.3 | +32% |
| 2022 | $21.3 | $19.0 | -11% |
| 2023 | $19.0 | $24.8 | +31% |
| 2024 | $24.8 | $35.4 | +43% |
| 2025 | $35.4 | $68.7 | +94% |
| 2026 YTD | $68.7 | $79.6 | +16% |
APH has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.